Genentech is informing its customers and distributors and is arranging for return of all impacted products. Genentech announced a voluntary recall of three lots of Activase (alteplase) 100mg vials ...
Roche’s subsidiary, Genentech, issued the voluntary recall of the anti-stroke drug because of compromised vials containing sterile water that were packaged with the drug. Roche’s Genentech is ...
Here are five things to know. 1. Activase is used to treat acute ischemic strokes, which are caused by a blood clot in the brain, and heart attacks. 2. The recall applies to three lots of Activase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback